FCC finalizes spectrum rules for Medical Body Area Networks

The Federal Communications Commission (FCC) has finalized rules to set aside wireless spectrum for wearable sensors.

Medical Body Area Network (MBAN) technology provides a platform for the wireless networking of multiple wearable sensors used for measuring and recording physiological parameters and other patient information for use by healthcare facilities, according to the agency.

In 2012, the FCC voted to allocate spectrum in the 2360-2400 range for MBANs, with the 2360-2390 range for indoor use and the 2390-2400 range for outdoor use. However, given the explosion of mHealth technologies, FCC finalized a more expansive rule on Aug. 21.

“In addressing petitions for reconsideration of the First Report and Order in this proceeding, we provide MBAN users with additional flexibility to enable the implementation of technical standards being developed for MBAN devices, and clarify and modify portions of our rules to facilitate the coordination, deployment, and use of MBAN systems,” according to the FCC rule.

The rule also designates the position of an MBAN coordinator, who will separate wireless sensors from other systems—such as legacy wireless systems—in a healthcare setting.

The U.S. is the first country to designate spectrum for MBAN.

To read the full FCC document, go here.

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.